期刊文献+

银线草醇F:一种新结构类型HIV-1逆转录酶RNaseH活性抑制剂 被引量:5

Shizukaol F:a new structural type inhibitor of HIV-1 reverse transcriptase RNase H
原文传递
导出
摘要 乌药烷型二聚倍半萜类化合物银线草醇F具有抑制HIV-1复制活性,为研究该化合物的作用机制,应用实时荧光定量PCR法、ELISA法及荧光测定法分别测定化合物对HIV-1逆转录进程、逆转录酶RNA-依赖DNA聚合酶活性以及RNase H活性的影响。结果显示,银线草醇F抑制HIV-1逆转录产物LTR/Gag生成,IC50为9.11μmol·L 1,与HIV-1活病毒感染实验结果 (6.12μmol·L 1)一致;该化合物特异性抑制RNase H的活性,IC50为26.4μmol·L 1;对逆转录酶的RNA-依赖DNA聚合酶活性无显著影响。银线草醇F是一个作用于RNase H的具有新结构类型的HIV-1逆转录酶抑制剂。 This study is to investigate the mechanism of action of lindenane disesquiterpenoid shizukaol F on HIV-1 replication.Real time quantity PCR,ELISA assay and fluorescence methods were used to test HIV-1 reverse transcription process,RNA-dependent DNA polymerase activity,and RNase H activity,respectively.It showed that shizukaol F inhibited LTR/Gag production of HIV-1 reverse transcription with an IC50 of 9.11 μmol·L?1.This result is consistent with its inhibitory effect on HIV-1 replication(IC50 of 6.12 μmol·L?1).Mechanism studies showed that compound shizukaol F inhibited HIV-1 RT-RNase H with IC50 of 26.4 μmol·L?1,but had no effect on HIV-1 RT RNA-dependent DNA polymerase activity.In conclusion,shizukaol F is a new structural type HIV-1 RNase H inhibitor.This discovery will provide a clue for new type of reverse transcriptase inhibitors development.
出处 《药学学报》 CAS CSCD 北大核心 2012年第8期1011-1016,共6页 Acta Pharmaceutica Sinica
基金 天然药物活性物质与功能国家重点实验室开放课题(231776国天重-润楠属植物)
关键词 银线草醇F 乌药烷型二聚倍半萜类化合物 HIV-1 逆转录酶 RNASE H抑制剂 shizukaol F; lindenane disesquiterpenoid; HIV-1; reverse transcriptase; RNase H inhibitor
  • 相关文献

参考文献2

二级参考文献74

  • 1杨勤刚,何煦昌,白东鲁.HIV蛋白酶抑制剂研究进展[J].药学学报,2005,40(5):389-394. 被引量:16
  • 2Wainberg MA, Jeang KT. 25 years of HIV-1 research-progress and perspectives [J]. BMC Med, 2008.6: 31.
  • 3Luo MQ, Liu H, Zhuang K, et al. Prevalence of drug-resistant HIV-1 in rural areas of Hubei province in the People's Republic of China [J]. J Acquir Immune Defic Syndr, 2009, 50: 1-8.
  • 4Richman DD. HIV chemotherapy [J]. Nature, 2001, 410:995-1001.
  • 5Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial [J]. N Engl J Med, 1987, 317: 185-191.
  • 6Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection [J]. Nature, 1995, 373: 123-126.
  • 7Zhang L, Ramratnam B, Tenner-Racz K, et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy [J]. N Engl J Med, 1999, 340: 1605- 1613.
  • 8Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-I infection [J]. Nature, 1997, 387: 183-188.
  • 9Zhang F, Dou Z, Ma Y, et al. Five-year outcomes of the China national free antiretroviral treatment program [J]. Ann Intern Med, 2009, 151: 241-51, W-52.
  • 10Kati WM, Johnson KA, Jerva LF, et al. Mechanism and fidelity of HIV reverse transcriptase [J]. J Biol Chem, 1992, 267: 25988-25997.

共引文献28

同被引文献63

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部